Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideJNJJohnson & Johnson
FinDog View：Bullish
REGNRegeneron Pharmaceuticals
FinDog View：Neutral
| Metric | JNJ | REGN |
|---|
| Close | 273.20 | 927.89 |
| Market Cap | $666B | $93.4B |
| 1M | +3.20% | +22.37% |
| P/E (TTM) | 41.3 | 19.5 |
| Forward P/E | 22.0 | 13.4 |
| P/E 5-Yr Percentile | 100 | 56 |
| P/S | 6.7 | 5.4 |
| P/B | 7.8 | 2.7 |
| Dividend Yield | 3.12% | 0.45% |
| Latest Quarter Revenue | $25.4B | $5.1B |
| Revenue YoY | +5.9% | +36.3% |
| Gross Margin | 68.1% | — |
| Latest Quarter EPS | 0.09 | 18.45 |
| Avg Post-Earnings Move | ±0.6% | ±1.4% |
| EPS Beat Rate | 1 / 1 | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.18% | 3.66% |
| 90-Day Net Insider Buying | −$62.0M | −$6.5M |
JNJ · Revenue, Last 8 Quarters ($B)
REGN · Revenue, Last 8 Quarters ($B)
